Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.710
-0.020 (-1.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Ikena Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 0.66 | 9.16 | 15.62 | 30.99 | 9.19 | 13.75 | Upgrade
|
| Revenue Growth (YoY) | -95.28% | -41.35% | -49.59% | 237.01% | -33.15% | 1289.19% | Upgrade
|
| Cost of Revenue | 40.57 | 59.65 | 64.32 | 47.11 | 44.85 | 24.94 | Upgrade
|
| Gross Profit | -39.91 | -50.49 | -48.7 | -16.12 | -35.65 | -11.19 | Upgrade
|
| Selling, General & Admin | 24.38 | 24.93 | 22.2 | 18.02 | 8.87 | 7.31 | Upgrade
|
| Operating Expenses | 24.38 | 24.93 | 22.2 | 18.02 | 8.87 | 7.31 | Upgrade
|
| Operating Income | -64.29 | -75.42 | -70.9 | -34.14 | -44.52 | -18.49 | Upgrade
|
| Interest & Investment Income | 8.08 | 7.11 | 2.15 | 0.02 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.63 | -0.02 | -0.01 | - | 0.26 | 1.68 | Upgrade
|
| Pretax Income | -59.66 | -68.33 | -68.77 | -34.12 | -44.26 | -16.82 | Upgrade
|
| Income Tax Expense | -0.06 | -0.16 | - | - | - | - | Upgrade
|
| Net Income | -59.6 | -68.17 | -68.77 | -34.12 | -44.26 | -16.82 | Upgrade
|
| Net Income to Common | -59.6 | -68.17 | -68.77 | -34.12 | -44.26 | -16.82 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 42 | 36 | 28 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 42 | 36 | 28 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 24.03% | 15.33% | 29.32% | 911.88% | 4.43% | 55.37% | Upgrade
|
| EPS (Basic) | -1.24 | -1.63 | -1.90 | -1.22 | -16.00 | -6.35 | Upgrade
|
| EPS (Diluted) | -1.24 | -1.63 | -1.90 | -1.22 | -16.00 | -6.35 | Upgrade
|
| Free Cash Flow | -61.83 | -80.16 | -75.54 | -62.01 | -38.59 | 47.61 | Upgrade
|
| Free Cash Flow Per Share | -1.28 | -1.92 | -2.09 | -2.22 | -13.95 | 17.98 | Upgrade
|
| Gross Margin | - | - | - | -52.03% | - | -81.33% | Upgrade
|
| Operating Margin | -9755.24% | -823.33% | -453.99% | -110.18% | -484.22% | -134.46% | Upgrade
|
| Profit Margin | -9043.85% | -744.17% | -440.29% | -110.10% | -481.36% | -122.28% | Upgrade
|
| Free Cash Flow Margin | -9381.64% | -875.08% | -483.67% | -200.14% | -419.75% | 346.19% | Upgrade
|
| EBITDA | -63.58 | -74.4 | -70.15 | -33.59 | -44.22 | -18.25 | Upgrade
|
| EBITDA Margin | - | - | - | -108.42% | - | -132.69% | Upgrade
|
| D&A For EBITDA | 0.71 | 1.02 | 0.75 | 0.54 | 0.3 | 0.24 | Upgrade
|
| EBIT | -64.29 | -75.42 | -70.9 | -34.14 | -44.52 | -18.49 | Upgrade
|
| EBIT Margin | - | - | - | -110.18% | - | -134.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.